Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
First Opinion
The Readout

Getting patients to stick with their meds & why PBMs are not fond of transparency

  • Damian Garde
  • Meghana Keshavan

By Damian Garde and Meghana Keshavan Sept. 14, 2017

Reprints
The READOUT
Alex Hogan/STAT

The Readout for September 14, 2017

About the Authors Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

In Philadelphia, ‘tranq’ is leaving drug users with horrific…
In Philadelphia, ‘tranq’ is leaving drug users with horrific wounds. Other communities are bracing for the…
Human reproductive cloning: The curious incident of the dog…
Human reproductive cloning: The curious incident of the dog in the night-time
Health websites are notoriously misleading. So we rated their…
Health websites are notoriously misleading. So we rated their reliability
Regeneron targets obesity, a new microbiome deal, & comparing…
Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries…
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Docs disagree with FDA on Aduhelm, Swiss giants pinch…
Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain

Recommended Stories